Page 1176 - Cote clinical veterinary advisor dogs and cats 4th

Leukemias, Acute 588.e1

ADDITIONAL SUGGESTED RELATED CLIENT EDUCATION
READINGS SHEETS
VetBooks.ir Bennett AL, et al: Canine acute leukaemia: 50 cases Consent to Administer Chemotherapy Diseases and Disorders
(1989-2014). Vet Comp Oncol 15:1101-1114,
Leukemia
2017.
Giantin M, et al: Evaluation of tyrosine-kinase
receptor c-KIT (c-KIT) mutations, mRNA and
protein expression in canine leukemia: might
c-KIT represent a therapeutic target? Vet Immunol
Immunopathol 152:325-332, 2013.
Juopperi TA, et al: Prognostic markers for myeloid
neoplasms: a comparative review of the literature
and goals for future investigation. Vet Pathol
48:182-197, 2011.
McManus PM: Classification of myeloid neoplasms:
a comparative review. Vet Clin Pathol 3:189-212,
2005.
Tasca S, et al: Hematologic abnormalities and flow
cytometric immunophenotyping results in dogs
with hematopoietic neoplasia: 210 cases (2002-
2006). Vet Clin Pathol 38:2-12, 2009.
Usher SG, et al: RAS, FLT3, and C-KIT mutations
in immunophenotyped canine leukemias. Exp
Hematol 37:65-77, 2009.
Vernau W, et al: An immunophenotypic study of
canine leukemias and preliminary assessment
of clonality by polymerase chain reaction. Vet
Immunol Immunopathol 69:145-164, 1999.
Williams MJ, et al: Canine lymphoproliferative disease
characterized by lymphocytosis: immunophenotypic
markers of prognosis. J Vet Intern Med 22:596-601,
2008.

www.ExpertConsult.com